CELH SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Celsius Holdings Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

Faruqi & Faruqi says it is investigating potential claims against Celsius Holdings and notes that a federal securities class action has been filed against the company. Investors who purchased or acquired Celsius securities from February 21, 2025, through June 3, 2026, have until November 3, 2026, to seek lead-plaintiff status.

Analysis

This is a procedural litigation update, not new evidence that the claims have merit or that Celsius Holdings faces a quantified liability. The lead-plaintiff deadline may generate another round of headlines, but by itself is a weak basis for revising earnings or valuation expectations. The material unknown is the complaint’s specific alleged misstatements, the period and metrics implicated, and whether any regulatory inquiry or company disclosure corroborates them.

Near term, CELH could see headline-driven volatility or a modest risk-premium increase, particularly if investors are already focused on disclosure credibility. A larger, durable impact would require evidence tying the allegations to sales, channel inventory, guidance, or controls; only then would there be a plausible pathway from legal uncertainty to estimates, distributor confidence, or a lower multiple. Competitors such as Monster Beverage and PepsiCo could benefit at the margin if Celsius-specific reputational concerns affect retail placement or consumer demand, but no such substitution is established here.

Over the next 1–3 months, track court filings, any company response, and subsequent guidance for concrete operational implications. Over 6–18 months, the key risk is not the filing itself but a substantiated disclosure or governance issue that changes investor confidence and the durability of growth expectations. Contrarian view: investors may overread a law-firm solicitation as confirmation of wrongdoing; absent new factual allegations, this is more likely legal overhang than a standalone fundamental catalyst. No directional trade is warranted on this item alone.

Key Decisions for Investors

• Do not initiate a CELH short or buy event-driven options solely on the solicitation or lead-plaintiff deadline; the information provided does not establish liability, damages, or earnings exposure.
• Review the underlying complaint and subsequent court filings before changing estimates. Verify the alleged statements, affected reporting periods, claimed loss mechanism, and whether any independent regulator or company disclosure supports them.
• Keep CELH on a headline-risk watch through the November 3, 2026 deadline and the next earnings/guidance update. Escalate only if filings or disclosures connect the claims to sales, channel inventory, controls, or guidance.
• Falsification of a bearish legal-overhang thesis: no substantiated operational or disclosure issue emerges, and CELH maintains guidance and relevant operating indicators. A credible allegation or adverse ruling tied to material company disclosures would warrant reassessing exposure.